|Bid||0.1750 x 0|
|Ask||0.1800 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan. 28, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (CSE: SPR) (FRA: 38G) (OTCQB: SRUTF) ("Sproutly" or the "Company") today announced the Company’s financial results for the third quarter ended November 30, 2019.
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to announce it has secured a private loan (the "Loan") of $1 million from Infusion Biosciences Inc., a related party of the Company (the "Lender"). The Loan carries an interest rate of 10% per annum accruing and compounding monthly, payable on maturity on or before October 24, 2020 (the "Maturity Date"). The Company anticipates using the proceeds of the Loan to support the Company’s general working capital.
A desire to move away from smoking may be fueling growth in the edible cannabis products. The shift toward edibles is a direct response to the decrease in smoking. Cannabis legalization has arrived just as tobacco smoking is seeing a steep decline.
NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Sproutly Canada Inc. (SRUTF) (CSE:SPR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. As the legal boundaries of the North American cannabis industry expand, businesses are looking for ways to make the most of their products and reach the widest possible market. Instead, companies are increasingly focused on alternatives such as edible cannabis products.
The newly legal Canadian cannabis market is a rapidly-developing frontier that analysts unanimously ...